Application 204209

Type
ANDA
Sponsor
LARKEN LABS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATEACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATETABLET;ORAL325MG;30MG;16MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A204209-001ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATEACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE325MG;30MG;16MGTABLET / ORAL2016-09-30

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A204209-001ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE325MG;30MG;16MGTABLET / ORAL2016-09-303a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A204209-001ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE325MG;30MG;16MGTABLET / ORAL2016-09-30f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A204209-001ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE325MG;30MG;16MGTABLET / ORAL2016-09-30e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A204209-001ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE325MG;30MG;16MGTABLET / ORAL2016-09-30cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A204209-001ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE325MG;30MG;16MGTABLET / ORAL2016-09-30a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 9 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
68047-720Acetaminophen, Caffeine and Dihydrocodeine BitartrateAcetaminophen, Caffeine and Dihydrocodeine BitartrateLarken Laboratories Inc.ANDACurrent
68047-720Acetaminophen, Caffeine and Dihydrocodeine BitartrateAcetaminophen, Caffeine and Dihydrocodeine BitartrateLarken Laboratories Inc.ANDACurrent
68047-720Acetaminophen, Caffeine and Dihydrocodeine BitartrateAcetaminophen, Caffeine and Dihydrocodeine BitartrateLarken Laboratories Inc.ANDACurrent
70362-730DVORAHacetaminophen, caffeine and dihydrocodeine bitartrateSkylar Laboratories, LLCANDACurrent
70362-730DVORAHacetaminophen, caffeine and dihydrocodeine bitartrateSkylar Laboratories, LLCANDACurrent
70362-730DVORAHacetaminophen, caffeine and dihydrocodeine bitartrateSkylar Laboratories, LLCANDACurrent
70569-152DVORAHacetaminophen, caffeine and dihydrocodeine bitartratePhlight Pharma, LLCANDACurrent
70569-152DVORAHacetaminophen, caffeine and dihydrocodeine bitartratePhlight Pharma, LLCANDACurrent
71993-300Acetaminophen, Caffeine and Dihydrocodeine BitartrateAcetaminophen, Caffeine and Dihydrocodeine BitartrateAtland Pharmaceuticals, LLCANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
76103ORIG 2023-11-02
45590ORIG2016-10-05